[go: up one dir, main page]

NO20080158L - Oyedraper som inneholder roflumilast - Google Patents

Oyedraper som inneholder roflumilast

Info

Publication number
NO20080158L
NO20080158L NO20080158A NO20080158A NO20080158L NO 20080158 L NO20080158 L NO 20080158L NO 20080158 A NO20080158 A NO 20080158A NO 20080158 A NO20080158 A NO 20080158A NO 20080158 L NO20080158 L NO 20080158L
Authority
NO
Norway
Prior art keywords
roflumilast
oyadraper
containing roflumilast
efficiency
increased
Prior art date
Application number
NO20080158A
Other languages
English (en)
Norwegian (no)
Inventor
Yoko Endo
Aiko Kimura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20080158L publication Critical patent/NO20080158L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20080158A 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast NO20080158L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005169015 2005-06-09
PCT/JP2006/311576 WO2006132342A1 (fr) 2005-06-09 2006-06-09 Gouttes oculaires contenant du roflumilast

Publications (1)

Publication Number Publication Date
NO20080158L true NO20080158L (no) 2008-03-04

Family

ID=37498536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080158A NO20080158L (no) 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast

Country Status (8)

Country Link
US (1) US20090209599A1 (fr)
EP (1) EP1889620A4 (fr)
KR (1) KR20080029974A (fr)
CN (1) CN101193634A (fr)
CA (1) CA2610881A1 (fr)
NO (1) NO20080158L (fr)
RU (1) RU2007149249A (fr)
WO (1) WO2006132342A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130274332A1 (en) * 2010-12-17 2013-10-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition for contact lens
CN102793684B (zh) * 2011-05-26 2016-02-17 杭州赛利药物研究所有限公司 罗氟司特液体制剂及其制备方法
EP2730292A4 (fr) * 2011-07-08 2015-01-14 Rohto Pharma Composition ophtalmique aqueuse
JP6462201B2 (ja) * 2012-06-14 2019-01-30 ロート製薬株式会社 水性眼科組成物
JP5988855B2 (ja) 2012-06-27 2016-09-07 ロート製薬株式会社 水性眼科組成物
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
CA3001955C (fr) 2015-10-16 2023-11-28 Sun Pharma Advanced Research Company Limited Solution ophtalmique de difluprednate
WO2017083167A1 (fr) 2015-11-10 2017-05-18 Ocular Technologies Sarl Formulations topiques et utilisations associées
AU2017227585C1 (en) 2016-02-29 2022-05-26 Sun Pharmaceutical Industries Limited Topical cyclosporine-containing formulations and uses thereof
CA3201220A1 (fr) * 2020-12-03 2022-06-09 Ajay Jaysingh Khopade Difluprednate servant a reduire les effets indesirables de l'inflammation oculaire
WO2022173923A1 (fr) * 2021-02-10 2022-08-18 Iolyx Therapeutics, Inc. Procédés d'administration ophtalmique de roflumilast
CN116867480A (zh) * 2021-02-10 2023-10-10 洛利克斯治疗有限公司 眼部递送罗氟司特的方法
WO2023049809A1 (fr) * 2021-09-22 2023-03-30 Iolyx Therapeutics, Inc. Méthodes de traitement de maladies inflammatoires oculaires
IL319347A (en) * 2022-09-16 2025-05-01 Iolyx Therapeutics Inc Pharmaceutical preparations of roflumilast in high concentrations for ophthalmic administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
JP3631490B2 (ja) * 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
SI0706513T1 (en) * 1993-07-02 2002-10-31 Altana Pharma Ag Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
AU4558800A (en) * 1999-05-04 2000-11-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination comprising roflumilast and a pde-3 inhibitor
DK2020243T3 (en) * 2002-05-28 2018-11-19 Astrazeneca Ab Pharmaceutical composition which can be applied topically

Also Published As

Publication number Publication date
KR20080029974A (ko) 2008-04-03
EP1889620A4 (fr) 2008-12-10
CA2610881A1 (fr) 2006-12-14
CN101193634A (zh) 2008-06-04
EP1889620A1 (fr) 2008-02-20
US20090209599A1 (en) 2009-08-20
WO2006132342A1 (fr) 2006-12-14
RU2007149249A (ru) 2009-07-20

Similar Documents

Publication Publication Date Title
NO20080158L (no) Oyedraper som inneholder roflumilast
NO20083630L (no) Nye pyridinderivater
NO20082793L (no) Nye tiofenderivater
NO20091395L (no) Nye tiofenderivater
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
NO20083462L (no) Nye tiofenderivater som S1P1/EDG1-reseptoragonister
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EP3542629A3 (fr) Composés dithiols, dérivés et leurs utilisations
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
WO2008110308A3 (fr) Nouveaux herbicides
NO20076648L (no) Novel thiophene derivatives
MX2009009290A (es) Compuestos activos en ppar.
WO2009137391A3 (fr) Composés de benzène sulfonamide thiazole et oxazole
UY33397A (es) Forma sólida de un naftaleno carboxamida
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
MX2010004576A (es) Derivados de pirimidina novedosos.
MX374694B (es) USO DE 1-CLORO-4-(ß-D-GLUCOPIRANOS-1-IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)-BENCIL]-BENCENO EN COMBINACIÓN CON INSULINA PARA REDUCIR LA DOSIS DE INSULINA Y PARA MEJORAR EL CONTROL GLUCÉMICO EN PACIENTES CON DIABETES MELLITUS.
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
WO2007101864A3 (fr) Nouveaux composés, leur préparation et utilisation
WO2011143772A9 (fr) Inhibiteurs de la réplication du vih
TW200942530A (en) Pyridine compounds
WO2008151828A8 (fr) Nouveaux microbiocides
UA106880C2 (uk) Нові гербіциди

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application